Immunohistochemical analysis further showed reduced expression of KI-67 and FAM84A in tumors from the shFAM84A group (Fig. 9F), confirming that FAM84A silencing effectively suppresses CRC progression in vivo. Here, LRATD1 is linked to colorectal carcinoma.